0000899243-22-021396.txt : 20220607
0000899243-22-021396.hdr.sgml : 20220607
20220607193748
ACCESSION NUMBER: 0000899243-22-021396
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220606
FILED AS OF DATE: 20220607
DATE AS OF CHANGE: 20220607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lo Steven
CENTRAL INDEX KEY: 0001501959
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36570
FILM NUMBER: 221002313
MAIL ADDRESS:
STREET 1: C/O CORCEPT THERAPEUTICS
STREET 2: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zosano Pharma Corp
CENTRAL INDEX KEY: 0001587221
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454488360
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 34790 ARDENTECH COURT
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 510-745-1200
MAIL ADDRESS:
STREET 1: 34790 ARDENTECH COURT
CITY: FREMONT
STATE: CA
ZIP: 94555
FORMER COMPANY:
FORMER CONFORMED NAME: ZP Holdings Inc
DATE OF NAME CHANGE: 20130919
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-06
0
0001587221
Zosano Pharma Corp
ZSAN
0001501959
Lo Steven
C/O ZOSANO PHARMA CORPORATION
34790 ARDENTECH COURT
FREMONT
CA
94555
1
1
0
0
Chief Executive Officer
Common Stock
2022-06-06
4
S
0
442
0.71
D
13163
D
The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to restricted stock units of the Issuer.
Reflects a 1-for-35 reverse stock split of the Issuer's common stock, effected on April 11, 2022.
/s/ Steven Lo
2022-06-07